Using same proprietary, patented technology, VIVI Med extends the product portfolio beyond injectable pens, opening access to broader patient populations, premium ...

As AI tools spark a global SaaS sell-off, Australia’s top VCs say the business model isn’t dying, but being reshaped, ...

Predictive cancer diagnostics company Rhythm Biosciences has achieved a major milestone with the peer-reviewed validation of ...

Next-generation, all-in-one perforating command hub obliterates decades-old multi-box complexity, delivering 2x faster ...

Cardamyst FDA approval and launch for PSVT, solid cash, and big expansion upside. Click for more on MIST stock.

Briony was sent a lot of hardware by MSI, so she decided instead of just a plain review of the msi Vampiric 010 case, that she would handle a full build into it. It's a rather inexpensive £50 case, so ...

American Journal of Transplantation position paper also highlights value of absolute quantification of dd-cfDNA as a diagnostic marker, a key ...

RZOLV Technologies Inc. (TSXV: RZL) (the "Company" or "RZOLV") today announced the results of independent metallurgical ...

2025 total revenue expected to exceed $340 million, above the previously guided range of $327-335 million 2025 total test reports for our core revenue drivers (DecisionDx-Melanoma, TissueCypher) ...

2025 total revenue expected to exceed $340 million, above the previously guided range of $327-335 million 2025 total test ...

Aehr Test Systems (NASDAQ:AEHR) Q2 2026 Earnings Call Transcript January 8, 2026 Aehr Test Systems beats earnings expectations. Reported EPS is $-0.04, expectations were $-0.08. Operator: Greetings.

(Family Features) As you age, your doctor’s interest in your cholesterol level is likely to increase. That’s no coincidence. High cholesterol and age are two significant risk factors for heart disease ...